ITI-OC FOUNDERS: RANDALL CAUDILL & PATRICIA DUNN
RANDALL CAUDILL
As co-founder with Pattie Dunn of the Ovarian Cancer Vaccine Initiative, Randall was the prime mover behind identifying and advocating its support for the groundbreaking work being led by Dr. George Coukos under Carl June’s leadership as head of Translational Research at the Abramson Cancer Center of the University of Pennsylvania. Randall’s longtime professional interest in immune therapy was accelerated when his wife, Lee, was diagnosed with ovarian cancer in 2004.
Since 1997, Randall has been President of Dunsford Hill Capital Partners, a financial consulting firm specializing in complex advisory transactions with an emphasis on mergers, acquisitions, joint ventures, spinouts, and private equity financings.
Prior to forming Dunsford Hill Capital Partners, Randall was with Prudential Securities, where he established and headed its San Francisco investment banking practice in 1993 after serving as Head of the Mergers and Acquisitions Department and Co-Head of their Investment Bank. Randall served on most of Prudential Securities’ key committees including the firm’s Operating Council, Business Review Committee, and Equity Development Committee and supervised the investment of the Prudential Securities partners’ capital as a director of PB Capital Partners.
Prior to joining Prudential Securities, Randall was Executive Director and Co-Head of Mergers and Acquisitions at Morgan Grenfell, Inc. from 1982 to 1987. Previously, he was a senior executive in the international Mergers and Acquisitions Department of The First Boston Corporation.
Virtually all of Mr. Caudill’s investment banking career has been devoted to complex advisory activities and merger, acquisition, financing and valuation assignments. Randall currently serves on the boards of VaxGen Inc. (Chairman), Helix BioMedix Inc., SCOLR Pharma Inc., and Ramgen Power Systems Inc. He received his MPPM from Yale University, and his D.Phil. from Oxford University, where he was a Rhodes Scholar and teaching fellow.
PATRICIA DUNN
Patricia (Pattie) Dunn co-founded the ITI-OC with Randall Caudill in 2007 to foster the development of immune therapy to treat advanced ovarian cancer, with which she was diagnosed with in 2004.
Ms. Dunn led Barclays Global Investors, the world’s largest institutional investment management firm, from 1996 to 2002, having been with the firm and its predecessor companies since 1976. She served in a variety of portfolio management, trading, client service and sales positions before joining the firm’s senior management team in the mid-1980s. Ms. Dunn was appointed President of the firm in 1994, Co-Chairman in 1996, and Global Chief Executive Officer in 1998. Ms. Dunn stepped down as CEO for health reasons in 2002 and served in a non-executive capacity as Vice Chairman until October, 2006. Ms. Dunn joined the board of Hewlett-Packard Company in 1998 and was named Non-Executive Chairman in February, 2005. She resigned from the H-P Board in September, 2006.
Ms. Dunn was named one of the top women business executives in the US by Fortune Magazine in 2000 and 2001, received the Annual Achievement Award of the Financial Women’s Association of San Francisco in 2001, the “Aiming High” Award of the NOW Legal Defense & Education Fund in 2002, and was inducted into the Bay Area Council Business Hall of Fame in September, 2006. In 2008, Ms. Dunn received the Dignity Award from the Women’s Cancer Research Foundation.
Ms. Dunn is a director and member of the Executive Committee of Larkin Street Youth Services in San Francisco, a member of the Board of the UC Berkeley Haas Graduate School of Business and the Rock Center for Corporate Governance at Stanford University. She is also a member of the Executive Committee and the Board of Governors of the San Francisco Symphony, is a director and member of the Executive Committee of the UCSF Medical Center Foundation, and serves on the board of the Ohana Foundation in Kona, Hawaii. She is a graduate of the University of California at Berkeley.